Blood News and Research

RSS

Hesperos’ immune system-on-a-chip emulates immune reactions for tissue damage and acute inflammation

Hesperos Inc., pioneers of the Human-on-a-Chip in vitro system, today announced the publication of a new peer-reviewed publication that describes how the company’s technology can be used to investigate immune responses following treatment with biological therapeutics for multi-organ systemic diseases, including cancer, infectious diseases and inflammatory disorders.

4 Jun 2020

Base Genomics launches and raises $11 million USD to progress development of its TAPS technology

Epigenetics company Base Genomics has launched with a team of leading scientists and clinicians to set a new gold standard in DNA methylation detection.

4 Jun 2020

Brain activity studies are not as useful as previously thought

Hundreds of published studies over the last decade have claimed it's possible to predict an individual's patterns of thoughts and feelings by scanning their brain in an MRI machine as they perform some mental tasks.

3 Jun 2020

Study explores the role of mi RNAs in anticancer effect exerted by physical activity

Volume 11, Issue 22 of Oncotarget reported that the goal of this study was to explore the involvement of mi RNAs in beneficial effects exerted by physical activity in breast cancer prevention.

3 Jun 2020

Genetic variations linked to COVID-19 severity

A new report by researchers from Thailand's Mahidol University and published on the preprint server medRxiv in May 2020 reports that the clinical severity of COVID-19 may be linked to the genetic makeup of the patient in addition to external factors.

3 Jun 2020

Tumors cause disruption of the immune system throughout the body, study finds

Cancer treatment has advanced with the advent of immunotherapies that, in some cancers, can overcome tumors' ability to evade the immune system by suppressing local immune responses.

3 Jun 2020

Kawasaki-like inflammatory syndrome appears to be more common in children of African ancestry

An inflammatory syndrome in children and adolescents, believed to be linked to covid-19, seems to be more common among children of African ancestry, finds a small study from a hospital in Paris, published by The BMJ today.

3 Jun 2020

Women's risk for cardiovascular disease is lower than that of men

Women's risk of falling ill with cardiovascular disease, and dying from it, is lower than that of men of the same age, irrespective of where in the world they live.

3 Jun 2020

Researchers design new microfluidic device to help detect blood clots

Researchers in the Department of Biomedical Engineering at Texas A&M University are working on an entirely new way to detect blood clots, especially in pediatric patients.

3 Jun 2020

UC physician-researcher explores why TAVR doesn't work well for some patients

A University of Cincinnati physician-researcher says unlocking the key to how platelets function before, after and during transcatheter aortic valve replacement (TAVR) may provide insight as to why some patients undergoing the heart procedure have better outcomes than others.

3 Jun 2020

Artificial red blood cells mimic the favorable properties of natural ones

Scientists have tried to develop synthetic red blood cells that mimic the favorable properties of natural ones, such as flexibility, oxygen transport and long circulation times.

3 Jun 2020

Patients with ARDS, COVID-19 experience severe financial toxicity

It begins with shortness of breath. And for approximately one-third of patients, acute respiratory distress syndrome, or ARDS, ends in death. For those who survive, their lives are often turned upside-down.

3 Jun 2020

Octapharma extends support for COVID-19 study following promising preliminary data

Following positive preliminary data, Octapharma USA is extending funding for an investigator-initiated study (IIS) focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.

3 Jun 2020

Blood group type may affect susceptibility to COVID-19 respiratory failure

A group of over 120 researchers from various institutions across Europe has performed the first genome-wide association study to reveal host genetic factors that may contribute to respiratory failure in cases of coronavirus disease 209 (COVID-19).

3 Jun 2020

Study shows link between exposure to air pollution and vascular damage

A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, contributes new evidence about the negative impact of air pollution on cardiovascular health.

3 Jun 2020

Hype collides with science as FDA tries to rein in ‘Wild West’ of COVID blood tests

"Save your business while saving lives," reads the website of Because Health, a Seattle tech startup selling two types of tests to employers willing to pay $350 a pop to learn whether their workers have been infected with COVID-19.

3 Jun 2020

Spine surgeons across the world are experiencing the effects of COVID-19

Spine surgeons across the world are experiencing effects of COVID-19, including canceled procedures, changes in clinical roles, anxiety and risk of exposure to the disease themselves due to insufficient protective equipment. An international team of researchers reported these findings recently in the Global Spine Journal.

3 Jun 2020

New drug can prevent life-threatening anaphylaxis, shows study

For someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine study shows there might be a pill that can be taken proactively to prevent mild to life-threatening anaphylaxis, no matter the cause.

3 Jun 2020

Number of heart attack patients has dropped over 50% during COVID-19 outbreak

The number of heart attack patients seeking urgent hospital care has dropped by more than 50% during the COVID-19 outbreak, according to an extensive worldwide survey by the European Society of Cardiology (ESC).

3 Jun 2020

Researchers discover key gene essential for survival of leukemia stem cells

Acute myeloid leukemia (AML) is one of the most common forms of blood cancer among adults and is associated with a low survival rate, and leads to the inhibition of normal blood formation.

3 Jun 2020